文献速递临床微生物分子诊断临床免疫

非洲机构临床微生物与感染病检测能力调查

Survey of clinical microbiology and infectious disease testing capabilities among institutions in Africa.
PubMed 文献 · Am J Clin Pathol · 2025-01-01

该研究通过问卷调查了非洲28个国家131家机构的微生物检测能力,发现寄生虫学(80.9%,106/131)和细菌学(77.9%,102/131)服务最常见,而真菌学(45.0%,59/131)和病毒学(45.8%,60/131)较少。最常检测的病原体包括HIV(90.8%,119/131)、梅毒螺旋体(78.6%,103/131)、恶性疟原虫(76.3%,100/131)、结核分枝杆菌(76.3%,100/131)和丙型肝炎病毒(74.8%,98/131)。

要点

  • 非洲机构寄生虫学和细菌学服务较普及,真菌学和病毒学实验室较少。
  • HIV、梅毒螺旋体、恶性疟原虫、结核分枝杆菌和丙型肝炎病毒是检测最多的病原体。
  • 细菌鉴定是最常进行的细菌学检测(90.2%,92/102)。

核心结论

  • 调查提供了非洲机构关键感染病检测能力的现况数据。
  • 结果有助于确定实验室和公共卫生基础设施的战略投资方向。

研究设计与样本

  • 由主题专家设计问卷,评估非洲国家医院、政府实验室及独立公共和私人实验室的微生物检测能力。
  • 问卷通过美国临床病理学会邮件列表于2022年6月至8月分发。
  • 共28个国家的131家独特机构确认至少开展一种微生物学服务。

主要发现

  • 寄生虫学服务占80.9%(106/131),细菌学占77.9%(102/131),真菌学占45.0%(59/131),病毒学占45.8%(60/131)。
  • 在102家开展细菌学服务的机构中,细菌鉴定最常进行(90.2%,92/102),其次为需氧细菌培养和抗菌药物敏感性试验(均为89.2%,91/102)。
  • 在所有131家临床微生物/感染病实验室中,最常检测的病原体为HIV(90.8%,119/131)、梅毒螺旋体(78.6%,103/131)、恶性疟原虫(76.3%,100/131)、结核分枝杆菌(76.3%,100/131)和丙型肝炎病毒(74.8%,98/131)。

关键数值与推荐

  • 寄生虫学服务覆盖80.9%(106/131),细菌学77.9%(102/131),真菌学45.0%(59/131),病毒学45.8%(60/131)。
  • 细菌鉴定开展率90.2%(92/102),需氧细菌培养和抗菌药物敏感性试验均为89.2%(91/102)。
  • HIV检测率90.8%(119/131),梅毒螺旋体78.6%(103/131),恶性疟原虫76.3%(100/131),结核分枝杆菌76.3%(100/131),丙型肝炎病毒74.8%(98/131)。

临床怎么用

  • 可依据调查结果识别非洲实验室检测能力的薄弱环节,如真菌学和病毒学服务。
  • 针对高检测率病原体(如HIV、结核分枝杆菌)维持并优化检测流程。
  • 为战略投资实验室和公共卫生基础设施提供参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Inadequate laboratory infrastructure and testing capabilities are a major impediment to addressing the infectious disease burden in Africa. Therefore, the aims of this study were to characterize the clinical microbiology/infectious disease laboratory capabilities among countries in Africa. METHODS: A survey to assess the microbiological testing capabilities at hospitals, government laboratories, and free-standing public and private laboratories in African countries was developed by subject matter experts. Questions included institutional demographics and microbiology services in the broad categories of bacteriology, virology, mycology, parasitology, and rapid diagnostics/point-of-care testing. The survey was distributed using the American Society of Clinical Pathology email listserv between June and August 2022. RESULTS: In total, 131 unique institutions in 28 countries endorsed at least 1 type of microbiology service, with parasitology (80.9%, 106/131) and bacteriology (77.9%, 102/131) being most common, while mycology (45.0%, 59/131) and virology (45.8%, 60/131) laboratories were less prevalent. The most frequently performed bacteriology test was bacterial identification (90.2%, 92/102), followed by aerobic bacterial cultures and antimicrobial susceptibility testing (both 89.2%, 91/102). Among all clinical microbiology/infectious disease laboratories, the most commonly tested agents were HIV (90.8%, 119/131), Treponema pallidum (78.6%, 103/131), Plasmodium falciparum (76.3%, 100/131), Mycobacterium tuberculosis (76.3%, 100/131), and hepatitis C virus (74.8%, 98/131). CONCLUSIONS: These findings provide contemporary data regarding the availability of critical infectious disease testing capabilities among institutions in Africa. These results and future additional studies will be crucial for understanding where strategic investment in the laboratory and public health infrastructure is warranted.

来源:Am J Clin Pathol,查看原文。版权归原作者所有。

引用

  1. Jacobs JW, Adkins BD, Milner DA, et al. Survey of clinical microbiology and infectious disease testing capabilities among institutions in Africa. Am J Clin Pathol. 2025. PMID: 39531321. doi:10.1093/ajcp/aqae148

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。